- Home
- ERAS vs HNST Comparison
ERAS vs HNST Comparison
Compare ERAS & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- HNST
- Stock Information
- Founded
- ERAS 2018
- HNST 2012
- Country
- ERAS United States
- HNST United States
- Employees
- ERAS N/A
- HNST N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- HNST Catalog/Specialty Distribution
- Sector
- ERAS Health Care
- HNST Consumer Discretionary
- Exchange
- ERAS Nasdaq
- HNST Nasdaq
- Market Cap
- ERAS 439.7M
- HNST 405.0M
- IPO Year
- ERAS 2021
- HNST 2021
- Fundamental
- Price
- ERAS $2.44
- HNST $3.60
- Analyst Decision
- ERAS Buy
- HNST Buy
- Analyst Count
- ERAS 6
- HNST 5
- Target Price
- ERAS $3.67
- HNST $6.75
- AVG Volume (30 Days)
- ERAS 2.1M
- HNST 3.9M
- Earning Date
- ERAS 11-07-2025
- HNST 11-05-2025
- Dividend Yield
- ERAS N/A
- HNST N/A
- EPS Growth
- ERAS N/A
- HNST N/A
- EPS
- ERAS N/A
- HNST 0.06
- Revenue
- ERAS N/A
- HNST $389,783,000.00
- Revenue This Year
- ERAS N/A
- HNST $6.68
- Revenue Next Year
- ERAS N/A
- HNST $4.81
- P/E Ratio
- ERAS N/A
- HNST $59.26
- Revenue Growth
- ERAS N/A
- HNST 9.58
- 52 Week Low
- ERAS $1.01
- HNST $3.44
- 52 Week High
- ERAS $3.31
- HNST $8.97
- Technical
- Relative Strength Index (RSI)
- ERAS 59.41
- HNST 43.13
- Support Level
- ERAS $2.18
- HNST $3.44
- Resistance Level
- ERAS $2.65
- HNST $3.71
- Average True Range (ATR)
- ERAS 0.15
- HNST 0.14
- MACD
- ERAS -0.03
- HNST 0.00
- Stochastic Oscillator
- ERAS 55.79
- HNST 29.09
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.